Labcorp Tells Patent Board Genetic Testing Method Not Patentable

(June 1, 2021, 12:39 PM EDT) -- ALEXANDRIA, Va. — In a May 28 petition for inter partes review, a clinical laboratory network maintains that the Patent Trial and Appeal Board should cancel 19 claims of a patented method for detecting free nucleic acid as anticipated and rendered obvious by prior art....

Attached Documents

Related Sections